Ajanta Pharma fluphenazine tablets recalled for high impurity level
Ajanta Pharma USA Inc. is recalling fluphenazine hydrochloride 1mg tablets (NDC 27241-255-01) because stability testing at 18 months found organic impurity levels slightly above specification limits. The tablets contained 1.1% of Impurity-A, exceeding the 1.0% specification. No injuries have been reported.
From the FDA notice · Read the official notice ↗ · All Ajanta Pharma recalls
What to do
- If you take fluphenazine tablets from lot DJ23254 (expires 11/30/2026) or lot DJ10205 (expires 04/30/2027), contact your pharmacy or doctor.
- Do not stop taking your medication without talking to your doctor first.
- Return unused tablets to your pharmacy for safe disposal.
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- Fluphenazine Hydrochloride Tablets, USP, 1mg, 100-count bottles, Rx Only, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807, Made in India, NDC 27241-255-01.
- Sold in
- Nationwide
- Made for
- Adults (0 months and older)
Details
- Units affected
- 403,200 tablets
- Illnesses reported
- None reported
- Manufactured in
- 400 Crossing Blvd Ste 102, Bridgewater, NJ, United States
- Classification
- Class III
- Recall number
- D-0836-2026
In the FDA's words
- Description
- Fluphenazine Hydrochloride Tablets, USP, 1mg, 100-count bottles, Rx Only, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807, Made in India, NDC 27241-255-01. Failed impurities/degradation specifications: (OOS) for Organic Impurities by HPLC (Impurity-A) during testing at the 18 months long term stability. Result: 1.1 percent. Spec: 1.0 percent. Lot #: DJ23254, Exp. Date 11/30/2026; DJ10205, Exp. Date 04/30/2027. Distribution: Nationwide within the U.S Affected quantity: 403,200 tablets
- Hazard
- Failed impurities/degradation specifications: (OOS) for Organic Impurities by HPLC (Impurity-A) during testing at the 18 months long term stability. Result: 1.1 percent. Spec: 1.0 percent.
More from Ajanta Pharma
See all- Ajanta Pharma ranolazine tablets recalled for failed dissolution
ModerateFDAOct 7, 2026